-

J&J-Stop TB Partnership Deal a Positive Step but More Is Needed, says AHF

LOS ANGELES--(BUSINESS WIRE)--With Johnson and Johnson (J&J) recently granting permission to Stop TB Partnership to distribute its generic TB drug bedaquiline (SIRTURO) to the majority of low- and middle-income countries, AIDS Healthcare Foundation (AHF) applauds Stop TB Partnership and the TB community overall for their strong leadership and advocacy in inking this vital agreement. While the deal is a positive step, AHF agrees with advocates, including Médecins Sans Frontières and others, that this is a short-term solution and urges J&J to do more for other lower-income countries that still lack access.

“Tuberculosis kills 1.6 million people annually and remains the leading cause of death for people living with HIV. We are glad to see steps in the right direction with the licensing agreement between J&J and Stop TB Partnership and hope the pharma giant continues to set a positive example for other drug manufacturers to follow for improved access to intellectual property to produce more affordable generic medicines,” said Terri Ford, Chief of Global Advocacy and Policy at AHF. “That said, this doesn’t let J&J off the hook for its past profiteering with its COVID-19 vaccine and other drugs. It shouldn’t take a massive advocacy campaign by civil society organizations for pharmaceutical companies to put lives before profit.”

While AHF is cautiously optimistic, details of this agreement must be made public. It is being reported that countries in Eastern Europe and Central Asia, which have some of the world’s highest burden of drug-resistant TB, are left out of the deal. AHF urges J&J to grant unfettered access to all countries that need this lifesaving medicine.

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation, the largest global AIDS organization, currently provides medical care and/or services to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region and Europe. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

Contacts

Ged Kenslea, Senior Director Communications, AHF
+1.323.308.1833 work
+1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

AIDS Healthcare Foundation


Release Versions

Contacts

Ged Kenslea, Senior Director Communications, AHF
+1.323.308.1833 work
+1.323.791.5526 mobile
gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF
+1 323.308.1829
denys.nazarov@aidshealth.org

More News From AIDS Healthcare Foundation

AHF: Florida Budget Becomes Law, Securing Reversal of HIV Drug Cuts

TALLAHASSEE, Fla.--(BUSINESS WIRE)--AHF: Florida Budget Becomes Law, Securing Reversal of HIV Drug Cuts...

After UN HIV Meeting, AHF Calls for Resources to Match Promises

LOS ANGELES--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) welcomed the engagement of Member States at the 2026 United Nations High-Level Meeting on HIV/AIDS, while emphasizing that millions of people living with HIV still do not have access to lifesaving treatment, and an estimated 1.2 million people acquire HIV each year. As governments reaffirm their commitment to ending AIDS as a public health threat, AHF urged that political promises be matched by the resources needed to turn commitmen...

Hantavirus Reveals Latin America Is Unprepared, Warns The Lancet Commentary

MEXICO CITY--(BUSINESS WIRE)--The Latin American Technical Working Group, composed of former health ministers from the region, public health experts, epidemiologists, academics, and civil society representatives, published a new comment in The Lancet arguing that Latin America urgently needs a regional rapid-response platform to prevent, prepare for, and respond to infectious threats. Read the full text in The Lancet here. The comment, written collectively by the Technical Working Group, takes...
Back to Newsroom